Lucerne ( Medicago sativa ) protein concentrate, hereinafter called the product, as specified in the Annex may be placed on the market in the Community as a novel food ingredient to be used in food supplements.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
2009/826/EC: Commission Decision of 13 October 2009 authorising the placing on the market of a leaf extract from Lucerne ( Medicago sativa ) as novel food or novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7641)
The maximum amount of protein extract from Lucerne ( Medicago sativa ) present in a portion recommended for daily consumption by the manufacturer shall be 10 g.
The designation of the novel food ingredient authorised by this Decision on the labelling of the foodstuff containing it shall be ‘Lucerne ( Medicago sativa ) protein’ or ‘Alfalfa ( Medicago sativa ) protein’.
This Decision is addressed to Luzerne — Recherche et Développement (L.-R.D.), Complexe agricole du Mont-Bernard, F-51000 Châlons-en-Champagne.
Schedules & Appendices
ANNEX
SPECIFICATIONS OF PROTEIN EXTRACT FROM LUCERNE ( MEDICAGO SATIVA )
Description
The Lucerne is processed within 2 hours after harvest. It is chopped and crushed. By passing through an oleaginous-type press, the Lucerne provides a fibrous residue and press juice (10 % of dry matter). The dry matter of this juice contains about 35 % of crude protein. The press juice (pH 5,8-6,2) is neutralised. Preheating and vapour injection allows coagulation of proteins associated with carotenoid and chlorophyll pigments. The protein precipitate is separated by centrifugation and thereafter dried. After adding ascorbic acid the Lucerne protein concentrate is granulated and stored in inert gas or in cold storage.
Composition of the protein extract from Lucerne ( Medicago sativa )
Protein
45-60 %
Fat
9-11 %
Free carbohydrates (soluble fibre)
1-2 %
Polysaccharides (insoluble fibre)
including cellulose
11-15 %
2-3 %
Minerals
8-13 %
Saponins
Not more than 1,4 %
Isoflavones
Not more than 350 mg/kg
Coumestrol
Not more than 100 mg/kg
Phytates
Not more than 200 mg/kg
L-canavanine
Not more than 4,5 mg/kg
Cite this act
2009/826/EC: Commission Decision of 13 October 2009 authorising the placing on the market of a leaf extract from Lucerne ( Medicago sativa ) as novel food or novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7641) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32009D0826
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com